Mini Review
Published on 21 Jul 2014
Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00177
- 11,253 views
- 7 citations
10 articles related to "Non Squamous Cell"
Articles
Original Research
Published on 04 Oct 2023
Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1207295
- 4,429 views
- 8 citations
Original Research
Published on 31 Oct 2023
A SEER database retrospective cohort of 547 patients with penile non-squamous cell carcinoma: demographics, clinical characteristics, and outcomes
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2023.1271913
- 3,322 views
- 2 citations
Systematic Review
Published on 22 Nov 2024
Prognosis prediction using significant pathological response following neoadjuvant immunotherapy in resectable non-small-cell lung tumors: a meta-analysis
in Thoracic Surgery
Frontiers in Surgery
doi 10.3389/fsurg.2024.1500593
- 2,238 views
- 1 citation
Original Research
Published on 13 Dec 2021
A Nomogram for Predicting Brain Metastasis in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection: A Competing Risk Analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.781340
- 3,583 views
- 9 citations
Systematic Review
Published on 08 Apr 2025
Adjuvant immunotherapy improves survival in completely resected stage IB–III NSCLC: a systematic review and meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1493221
- 5,179 views
- 1 citation
Original Research
Published on 22 Oct 2020
Overall Survival in Heart Disease–Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.572380
- 6,856 views
- 6 citations
Case Report
Published on 06 Feb 2024
Case report: Clinical complete response in advanced ALK-positive lung squamous cell carcinoma: a case study of successful anti-PD-1 immunotherapy post ALK-TKIs failure
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1360671
- 5,541 views
- 9 citations
Original Research
Published on 23 Feb 2024
Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50%
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1348034
- 5,925 views
- 3 citations
Original Research
Published on 30 Nov 2018
Radiographic Number of Positive Pelvic Lymph Nodes as a Prognostic Factor in Cervical Cancer Treated With Definitive Concurrent Chemoradiotherapy or Intensity-Modulated Radiotherapy
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2018.00546
- 6,162 views
- 23 citations